Stay ahead with today’s top stock market updates! RBI has denied IREDA’s equity request for a Nepal project, while Gensol promoters sold 2.37% equity to reinvest in the business. Lupin launched Rivaroxaban tablets in the US, and Tata Power signed a ₹49,000 crore MoU for 7,000 MW renewable projects in Andhra Pradesh. Shilpa Medicare’s Raichur unit received a USFDA observation, and Shiv Nadar transferred 47% of his HCL Corp stake to Roshni Nadar Malhotra. Bodal Chemicals will benefit from new anti-dumping duties on imports from China and Japan. Stay tuned for more market insights!
Let's catch up on the latest news from the stock market. From significant investments to major deals, appointments, and acquisitions, here’s a quick look at which stocks will be in focus in today's trade:
There is no alternative to renewable energy to save the world, says KPI Green Chairman Faruk Patel. In an exclusive interview with Moneycontrol Patel, adds the growth of the company would be phenomenal in the next five to ten years as it has already started showing good results YoY. The KPI Green Chief further further says that by 2025 the company aims to achieve 1000 Mega Watt target. Watch the interview!